Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Parkinson's Disease

  Free Subscription


27.02.2017

2 BMC Neurol
1 Exp Neurol
1 J Neural Transm (Vienna)
1 Lancet Neurol
6 Mov Disord
1 Nervenarzt
1 Neurology
2 Neuron
5 Neurosci Lett
2 PLoS One
1 Rev Neurol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    BMC Neurol

  1. DINKELBACH L, Moller B, Witt K, Schnitzler A, et al
    How to improve patient education on deep brain stimulation in Parkinson's disease: the CARE Monitor study.
    BMC Neurol. 2017;17:36.
    PubMed     Text format     Abstract available

  2. YORITAKA A, Abe T, Ohtsuka C, Maeda T, et al
    Erratum to: A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics.
    BMC Neurol. 2017;17:35.
    PubMed     Text format    


    Exp Neurol

  3. MONNOT C, Zhang X, Nikkhou-Aski S, Damberg P, et al
    Asymmetric dopaminergic degeneration and levodopa alter functional corticostriatal connectivity bilaterally in experimental parkinsonism.
    Exp Neurol. 2017 Feb 18. pii: S0014-4886(17)30048.
    PubMed     Text format     Abstract available


    J Neural Transm (Vienna)

  4. TKACZYNSKA Z, Pilotto A, Becker S, Graber-Sultan S, et al
    Association between cognitive impairment and urinary dysfunction in Parkinson's disease.
    J Neural Transm (Vienna). 2017 Feb 17. doi: 10.1007/s00702-017-1690.
    PubMed     Text format     Abstract available


    Lancet Neurol

  5. VOON V, Napier TC, Frank MJ, Sgambato-Faure V, et al
    Impulse control disorders and levodopa-induced dyskinesias in Parkinson's disease: an update.
    Lancet Neurol. 2017;16:238-250.
    PubMed     Text format     Abstract available


    Mov Disord

  6. MIKI Y, Yoshizawa T, Morohashi S, Seino Y, et al
    Neuropathology of PARK14 is identical to idiopathic Parkinson's disease.
    Mov Disord. 2017 Feb 17. doi: 10.1002/mds.26952.
    PubMed     Text format    

  7. HORVATH K, Aschermann Z, Kovacs M, Makkos A, et al
    Minimal clinically important differences for the experiences of daily living parts of movement disorder society-sponsored unified Parkinson's disease rating scale.
    Mov Disord. 2017 Feb 20. doi: 10.1002/mds.26960.
    PubMed     Text format     Abstract available

  8. EBRAHIMI R, Sobhani S, Abbastabar M
    Whether the dissociation between toxicity and alpha-synuclein inclusion will be a possible therapy for Parkinson's disease or not?
    Mov Disord. 2017;32:210.
    PubMed     Text format    

  9. ALBIN RL
    What would Dr. James Parkinson think today? II. Neuroimaging in Parkinson's disease.
    Mov Disord. 2017;32:179-180.
    PubMed     Text format    

  10. OLANOW CW, Kordower JH
    Targeting alpha-Synuclein as a therapy for Parkinson's disease: The battle begins.
    Mov Disord. 2017;32:203-207.
    PubMed     Text format    

  11. ROSA M, Arlotti M, Marceglia S, Cogiamanian F, et al
    Adaptive deep brain stimulation controls levodopa-induced side effects in Parkinsonian patients.
    Mov Disord. 2017 Feb 17. doi: 10.1002/mds.26953.
    PubMed     Text format    


    Nervenarzt

  12. ZACH H, Walter U, Liepelt-Scarfone I, Maetzler W, et al
    [Diagnostics of clinical and prodromal idiopathic Parkinson's disease : New criteria].
    Nervenarzt. 2017 Feb 17. doi: 10.1007/s00115-017-0290.
    PubMed     Text format     Abstract available


    Neurology

  13. MERY VP, Gros P, Lafontaine AL, Robinson A, et al
    Reduced cognitive function in patients with Parkinson disease and obstructive sleep apnea.
    Neurology. 2017 Feb 22. pii: 10.1212/WNL.0000000000003738.
    PubMed     Text format     Abstract available


    Neuron

  14. CAO M, Wu Y, Ashrafi G, McCartney AJ, et al
    Parkinson Sac Domain Mutation in Synaptojanin 1 Impairs Clathrin Uncoating at Synapses and Triggers Dystrophic Changes in Dopaminergic Axons.
    Neuron. 2017;93:882-896.
    PubMed     Text format     Abstract available

  15. AFLAKI E, Westbroek W, Sidransky E
    The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.
    Neuron. 2017;93:737-746.
    PubMed     Text format     Abstract available


    Neurosci Lett

  16. FATHALLA AM, Soliman AM, Moustafa AA
    Selective A2A receptors blockade reduces degeneration of substantia nigra dopamine neurons in a rotenone-induced rat model of Parkinson's disease: A histological study.
    Neurosci Lett. 2017;643:89-96.
    PubMed     Text format     Abstract available

  17. MIKI Y, Tanji K, Mori F, Kakita A, et al
    PLA2G6 accumulates in Lewy bodies in PARK14 and idiopathic Parkinson's disease.
    Neurosci Lett. 2017 Feb 14. pii: S0304-3940(17)30133.
    PubMed     Text format     Abstract available

  18. TANAKA K, Miyake Y, Fukushima W, Kiyohara C, et al
    Vitamin D receptor gene polymorphisms, smoking, and risk of sporadic Parkinson's disease in Japan.
    Neurosci Lett. 2017;643:97-102.
    PubMed     Text format     Abstract available

  19. CAO XY, Lu JM, Zhao ZQ, Li MC, et al
    MicroRNA biomarkers of Parkinson's disease in serum exosome-like microvesicles.
    Neurosci Lett. 2017 Feb 18. pii: S0304-3940(17)30161.
    PubMed     Text format     Abstract available

  20. LI Y, Huang J, Pang S, Wang H, et al
    Novel and functional ATG12 gene variants in sporadic Parkinson's disease.
    Neurosci Lett. 2017 Feb 13. pii: S0304-3940(17)30134.
    PubMed     Text format     Abstract available


    PLoS One

  21. CHAN RB, Perotte AJ, Zhou B, Liong C, et al
    Elevated GM3 plasma concentration in idiopathic Parkinson's disease: A lipidomic analysis.
    PLoS One. 2017;12:e0172348.
    PubMed     Text format     Abstract available

  22. BRYAN L, Kaye W, Antao V, Mehta P, et al
    Preliminary Results of National Amyotrophic Lateral Sclerosis (ALS) Registry Risk Factor Survey Data.
    PLoS One. 2016;11:e0153683.
    PubMed     Text format     Abstract available


    Rev Neurol

  23. MEJIA P, Piedra LM, Merchan-Del Hierro X
    [Rapidly progressive dementia and parkinsonism associated to multiple dural arteriovenous fistulas].
    Rev Neurol. 2017;64:214-218.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Parkinson's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: